Concepedia

Praveen Rajendran

PR

20

Publications

1.1K

Citations

17

H-Index

2004

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Oregon State University

Dabur Research Foundation (India)

Texas A&M University

Prevention Institute

Praveen Rajendran is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

2004–2022

20

Publications

20

Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells

Praveen Rajendran, Emily Ho, David E. Williams et al. · Clinical Epigenetics · 2011 · 206 citations · Full text

Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly

Praveen Rajendran, Barbara Delage, Wan Mohaiza Dashwood et al. · Molecular Cancer · 2011 · 123 citations · Full text

HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates

Praveen Rajendran, Ariam I. Kidane, Tianwei Yu et al. · Epigenetics · 2013 · 117 citations · Full text

, , +17

HDAC8 and STAT3 repress BMF gene activity in colon cancer cells

Yuki Kang, Hui Nian, Praveen Rajendran et al. · Cell Death and Disease · 2014 · 81 citations · Full text

Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity

Praveen Rajendran, Manu Jaggi, Manoj Kumar Singh et al. · Investigational New Drugs · 2007 · 69 citations

, , +6

Rows per page

1–5 of 20